Breyanzi (lisocabtagene maraleucel) - BMS
Kymriah (tisagenlecleucel-T) - Novartis
Tecartus (brexucabtagene autoleucel) - Gilead
Prevymis (letermovir) - Merck (MSD)
Yescarta (axicabtagene ciloleucel) - Gilead
https://distribution.us.m-anage.com/from.storage?image=iI8mZKVyQCOb0f6sZEQvomvywZJwGgBZKfo_toNQ1K92jtf798WCNMQ_O_dT8v-y0
 
Mousa Thalji, MD 1; Sairah Ahmed, MD 2; Sattva S. Neelapu, MD 2; Veronica Leautaud, PhD 3; Amy A. Ayers, MPH 2; Paolo Strati, MD 2; Ranjit Nair, MD 3; Amanda L. Olson, MD 4; Roy F. Chemaly, MD, MPH, FIDSA, FACP 5; Richard E. Champlin, MD 4; Fareed Khawaja, MD 6; George L. Chen, MD 4
 
Jan 8, 2026
 
Prev Next